Table of Contents
Definition / general | Essential features | Terminology | ICD coding | Epidemiology | Sites | Pathophysiology | Clinical features | Diagnosis | Laboratory | Radiology description | Radiology images | Prognostic factors | Case reports | Treatment | Clinical images | Gross description | Gross images | Microscopic (histologic) description | Microscopic (histologic) images | Cytology description | Positive stains | Negative stains | Electron microscopy description | Sample pathology report | Differential diagnosis | Additional references | Board review style question #1 | Board review style answer #1 | Board review style question #2 | Board review style answer #2Cite this page: Chapel DB, Husain AN. Peritoneal inclusion cyst. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/pleuraperitmulticysticmeso.html. Accessed May 29th, 2023.
Definition / general
- Multicystic mesothelioma is a bland mesothelial proliferation of uncertain pathogenesis
- Local recurrences are common but death from disease is exceptionally rare
Essential features
- F > M
- Multiloculated cysts lined by bland mesothelial cells
- Surgical resection is mainstay of treatment
- Approximately 50% recur but death from disease is exceptionally rare
Terminology
- Benign multicystic mesothelioma
- Benign cystic mesothelioma
- Cystic mesothelioma
- Multiloculated peritoneal inclusion cyst
- Peritoneal inclusion cyst(s)
ICD coding
- ICD-10: D19.1 - benign neoplasm of mesothelial tissue of peritoneum
Epidemiology
- Rare: accounts for 3 - 5% of peritoneal mesothelial lesions (Pleura Peritoneum 2019;4:20190024)
- 80 - 90% in women (Cancer 1982;50:1615, Am J Surg Pathol 1988;12:737, Hum Pathol 2003;34:369, Eur J Surg Oncol 2018;44:1100)
- Age at diagnosis: 11 - 77 years
- In women, most common in third and fourth decades (Cancer 1982;50:1615, Am J Surg Pathol 1988;12:737, Hum Pathol 2003;34:369, J Pediatr Adolesc Gynecol 2009;22:41, Eur J Surg Oncol 2018;44:1100)
- In men, most common in seventh decade (Hum Pathol 2003;34:369, Case Rep Pathol 2017;2017:9752908)
Sites
- Essentially all cases involve the pelvis (Am J Surg Pathol 1988;12:737, Cancer 1989;64:1336)
- Ovarian surface, peritoneal cul de sac and rectal serosa frequently involved
- Approximately half also involve the abdominal peritoneum (Am J Surg Pathol 1988;12:737, Cancer 1989;64:1336)
- Minority (~ 20%) also involve the retroperitoneum (Cancer 1989;64:1336)
Pathophysiology
- Unclear if neoplastic or reactive
- Factors favoring neoplastic pathogenesis (Am J Surg Pathol 1988;12:737, Eur J Surg Oncol 2018;44:1100):
- Progressive nature of untreated cases
- Rare transformation to malignant mesothelioma
- Inconstant association with prior surgery or inflammatory process
- Occasional co-occurrence with adenomatoid tumor or well differentiated papillary mesothelioma (Histopathology 1996;29:375, Curr Probl Cancer 2017;41:340, Ann Diagn Pathol 2019;38:43, Medicine (Baltimore) 2019;98:e15746)
- Factors favoring reactive pathogenesis (Cancer 1989;64:1336, Am J Surg Pathol 1986;10:844, Hum Pathol 2003;34:369):
- Frequent association with prior surgery, pelvic inflammatory disease, endometriosis or peritoneal dialysis
Clinical features
- Commonly presents with abdominal fullness, pain or urinary / bowel symptoms (Cancer 1982;50:1615)
- Rarely presents as incidental finding (Am J Surg Pathol 1988;12:737, Cancer 1989;64:1336)
- Palpable mass typical on physical examination
Diagnosis
- Laparoscopic exploration with tissue sampling (Cancer 1982;50:1615)
Laboratory
- CA125 may be mildly elevated (Case Rep Obstet Gynecol 2014;2014:852583, Obstet Gynecol Surv 2009;64:321)
Radiology description
- Ultrasound: multiloculated anechoic cysts (Curr Probl Cancer 2017;41:340, Obstet Gynecol Surv 2009;64:321)
- Computed tomography: multilocular low density, thin walled multicystic mass (Tumori 2008;94:14, Obstet Gynecol Surv 2009;64:321)
- MRI: multiple cysts - hypointense on T1, hyperintense on T2 (Clin Imaging 2017;42:133, Obstet Gynecol Surv 2009;64:321)
Prognostic factors
- Approximately 50% experience peritoneal recurrence after debulking surgery (Cancer 1982;50:1615, Cancer 1989;64:1336)
- Recurrence free interval ranged from 1.7 - 21 (median, 8) years in one series (Cancer 1989;64:1336)
- Multiple recurrences common (Cancer 1989;64:1336, Hum Pathol 2003;34:369)
- High peritoneal carcinomatosis index and incomplete resection associated with increased recurrence risk (Cancer 1989;64:1336, Eur J Surg Oncol 2018;44:1100)
- Complete cytoreduction with hyperthermic intraperitoneal chemotherapy associated with reduced recurrence risk (21% at 10 years) (Eur J Surg Oncol 2018;44:1100)
- Death from disease extremely rare (Am J Surg Pathol 1988;12:737, Cancer 1989;64:1336, Hum Pathol 2003;34:369)
- Very rare cases present with or progress to epithelioid malignant mesothelioma (Am J Surg Pathol 1988;12:737, BMJ Case Rep 2014;2014:bcr2013200212, J Surg Oncol 2002;79:243)
Case reports
- 28 year old woman with pelvic multicystic mesothelioma (Obstet Gynecol Sci 2013;56:126)
- 47 year old woman with multicystic mesothelioma presenting as a pelvic mass (Obstet Gynecol Sci 2018;61:170)
- 47 year old woman with pelvic multicystic mesothelioma (Int J Surg Case Rep 2020;74:152)
- 68 year old man with multicystic mesothelioma of the abdomen and pelvis (Case Rep Pathol 2017;2017:9752908)
- 84 year old man with multicystic mesothelioma (Diagn Interv Imaging 2016;97:361)
Treatment
- Early complete surgical resection is first line therapy (Am J Surg Pathol 1988;12:737, Eur J Surg Oncol 2018;44:1100)
- Recurrence(s) managed by repeat resection
- Hyperthermic intraperitoneal chemotherapy advocated by some (Eur J Surg Oncol 2018;44:1100, Br J Surg 2011;98:60)
- Other options include hormonal therapy, sclerotherapy or laser ablation (Korean J Radiol 2001;2:164, Curr Probl Cancer 2017;41:340)
- No role for radiotherapy or systemic chemotherapy
Gross description
- Multiloculated cystic lesion, ranging from 4 to > 20 cm (Cancer 1982;50:1615, Cancer 1989;64:1336)
- Occasional cases comprise numerous discrete cysts studding peritoneum (Am J Surg Pathol 1988;12:737)
- Rare cases present with free floating intraperitoneal cysts (Cancer 1989;64:1336)
- Individual locules range from 0.2 - 15 cm (Cancer 1982;50:1615, Cancer 1989;64:1336, Am J Surg Pathol 1988;12:737, Hum Pathol 2003;34:369)
- Pink-tan to green-gray to purple-red
- Cysts filled with serous fluid; intracystic hemorrhage common
Microscopic (histologic) description
- Numerous small cysts lined by a single layer of bland, flat to cuboidal cells
- Delicate mesothelial papillae or buds may project into cyst lumina (Am J Surg Pathol 1988;12:737, Cancer 1989;64:1336)
- Cysts separated by scant loose to collagenous stromal septa
- No infiltrative invasion of underlying tissues (e.g., fat, bowel)
- Chronic inflammation and hemorrhage common
- Uncommon features (Am J Surg Pathol 1988;12:737)
- Adenomatoid tumor-like foci
- Squamous metaplasia of the mesothelial lining
- Hobnail change of mesothelial lining
- Brisk acute inflammation with mesothelial denudation and granulation type change
- Small mesothelial nests, cords and single cells in lesional stroma; often associated with brisk inflammation
- Mesothelial nests, cords and single cells may be seen in stromal septa, often associated with brisk inflammation (termed mural mesothelial proliferation) (Cancer 1989;64:1336, Am J Surg Pathol 1986;10:844, Hum Pathol 2003;34:369)
- Considered a superimposed reactive change
- No diffuse sheet-like growth or infiltration of underlying tissues
- Recurrences histologically similar to primary lesions (Cancer 1982;50:1615, Cancer 1989;64:1336)
Microscopic (histologic) images
Cytology description
- Nonspecific sheets or strips of flattened or squamoid cells with distinct cell borders and small bland nuclei (Diagn Cytopathol 2010;38:192, Cytopathology 2008;19:224, Obstet Gynecol Surv 2009;64:321)
Positive stains
- Cytokeratin
- Calretinin (Hum Pathol 2003;34:369, J Pediatr Adolesc Gynecol 2009;22:41)
- CK5/6
- WT1
- D2-40
- BAP1 (normal / retained)
- MTAP (normal / retained)
Negative stains
- ER, PR (focal weak staining in ~ 10%) (Hum Pathol 2003;34:369)
- Claudin4
- MOC31 / BerEP4
Electron microscopy description
- Well developed desmosomal attachments
- Numerous luminal microvilli
- Abundant cytoplasmic keratin filaments
- Ovoid nuclei with even chromatin
- Thin intact basal lamina (Cancer 1982;50:1615, Cancer 1989;64:1336)
Sample pathology report
- Pelvic mass, excision:
- Multicystic mesothelioma (6.5 cm) (see comment)
- Comment: On microscopic examination of this multiloculated cystic lesion, individual cysts are lined by bland, flattened mesothelial cells. Mitoses are not identified. The cysts are separated by fibrous septa with patchy chronic inflammation. There is no infiltration of underlying tissues. The gross and microscopic findings are most consistent with a diagnosis of multicystic mesothelioma (also termed multiloculated peritoneal inclusion cyst). Although multicystic mesothelioma is generally regarded as a benign lesion, local recurrence has been documented in up to 50% of cases. Recurrence is more common after incomplete excision. Progression to malignant mesothelioma has been reported in exceptionally rare cases. Clinical and radiographic correlation is advised with appropriate clinical followup.
Differential diagnosis
- Malignant mesothelioma:
- Infiltrates underlying native tissues (e.g., fat, muscle, viscera)
- Foci of expansile growth with tubulopapillary, papillary, glandular or solid architecture
- Typically shows at least moderate atypia and mitotic activity
- Approximately 80% will show BAP1 loss (IHC), CDKN2A deletion (FISH) or MTAP loss (IHC)
- Lymphangioma (Cancer 1982;50:1615, Am J Surg Pathol 1988;12:737, Hum Pathol 2003;34:369):
- Unifocal lesion
- Primarily seen in in retroperitoneum, mesentery or omentum
- Uniform cyst size without intraluminal mesothelial budding
- Endothelial lining positive for CD31, CD34, ERG
- Negative for cytokeratin, calretinin, WT1
Additional references
Board review style question #1
A 36 year old woman presents with pelvic discomfort, worsening over 6 months. Transvaginal ultrasound shows a multicystic lesion involving the cul de sac, left uterine adnexa and rectal serosa. The lesion is resected by laparoscopy. A representative H&E stained slide is shown. The cyst lining cells are positive for cytokeratin AE1 / AE3, calretinin and WT1 and negative for MOC31. The lesion is extensively sampled and no infiltrative growth is identified. Which of following is true?
- Approximately 70% of such lesions harbor BAP1 mutations
- Complex copy number alterations are characteristic of such lesions
- Excision is curative; no clinical followup is required
- Local recurrence affects approximately 50% of patients
- Men are affected approximately four times as often as women
Board review style answer #1
D. Local recurrence affects approximately 50% of patients. This is multicystic mesothelioma.
Comment Here
Reference: Multicystic mesothelioma
Comment Here
Reference: Multicystic mesothelioma
Board review style question #2
Which of the following statements regarding multicystic mesothelioma is true?
- 40 - 50% of lesions harbor homozygous deletion of CDKN2A
- Approximately 20% of patients progress to malignant mesothelioma over 10 years
- Destructive infiltration of underlying structures (e.g., omental fat) is seen in approximately 33% of cases and does not affect prognosis
- Over 90% of lesions express estrogen receptor and progesterone receptor
- Surgical excision is considered the mainstay of treatment
Board review style answer #2
E. Surgical excision is considered the mainstay of treatment
Comment Here
Reference: Multicystic mesothelioma
Comment Here
Reference: Multicystic mesothelioma